L1CAM is an independent predictor of poor survival in endometrial cancer - An analysis of The Cancer Genome Atlas (TCGA).
about
TWIST1 drives cisplatin resistance and cell survival in an ovarian cancer model, via upregulation of GAS6, L1CAM, and Akt signalling.L1CAM as a prognostic marker in stage I endometrial cancer: a validation study.Meta-analysis of gene expression studies in endometrial cancer identifies gene expression profiles associated with aggressive disease and patient outcome.Disseminated tumor cells are not associated with established risk factors, L1CAM immunoreactivity and outcome in endometrial carcinoma.L1CAM: amending the "low-risk" category in endometrial carcinoma.Prognostic significance of L1 cell adhesion molecule in cancer patients: A systematic review and meta-analysis.Expression of L1CAM in curettage or high L1CAM level in preoperative blood samples predicts lymph node metastases and poor outcome in endometrial cancer patients.L1CAM expression in endometrial carcinomas: an ENITEC collaboration study.The Significance of L1CAM Expression in Clear Cell Carcinoma of the Endometrium.Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification.Systematic Analysis of Transcriptomic Profile of Renal Cell Carcinoma under Long-Term Hypoxia Using Next-Generation Sequencing and Bioinformatics.L1CAM promotes epithelial to mesenchymal transition and formation of cancer initiating cells in human endometrial cancer.RNA-seq Reveals the Overexpression of IGSF9 in Endometrial Cancer.LYL1 gene amplification predicts poor survival of patients with uterine corpus endometrial carcinoma: analysis of the Cancer genome atlas data.Endometrial cancer prognosis correlates with the expression of L1CAM and miR34a biomarkers.
P2860
Q34545399-1343DD84-2FDF-4802-AFB2-7EC2BA494456Q36094419-C7E506AA-61A3-4FF2-BC53-CA0F54C55DF6Q37405608-AA5A3437-02C0-464B-91B2-C25F67767AF7Q38677937-F2B57F7E-E526-432D-8F1A-F97B9042380BQ38815450-67F30299-1826-4969-92DF-CA7BFDC713D0Q39004897-F19C1AFF-63F5-4D5B-8BD4-07B44B60E929Q40104862-AE9896B1-4463-4532-B3FC-2372CD06C4D1Q40629455-88BBD1C1-68AC-471F-96A6-C4A37463B7EEQ44324745-17CB7654-801B-401F-996B-3AD4B478E0AFQ46764265-4B7D9368-4797-4FC5-BA49-1303D492A1E1Q48160019-EFF59871-98EA-486B-BC42-52A0EC5FB300Q49875592-C6EB3D83-137A-4F0E-9F3B-D4833CE97E0FQ52581831-73BAAFC9-92CC-4C9B-9265-04F6AF1D1FE0Q52715015-A73280E5-8A66-4854-9E84-EC0A8CEA3CDBQ55510327-A73A5A85-A5E9-4088-8F65-7CA75996D17C
P2860
L1CAM is an independent predictor of poor survival in endometrial cancer - An analysis of The Cancer Genome Atlas (TCGA).
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
L1CAM is an independent predic ...... he Cancer Genome Atlas (TCGA).
@en
type
label
L1CAM is an independent predic ...... he Cancer Genome Atlas (TCGA).
@en
prefLabel
L1CAM is an independent predic ...... he Cancer Genome Atlas (TCGA).
@en
P2093
P2860
P1433
P1476
L1CAM is an independent predic ...... he Cancer Genome Atlas (TCGA).
@en
P2093
Charles D Warden
Ching Ouyang
Ernest S Han
John C Williams
P2860
P304
P356
10.1016/J.YGYNO.2016.02.003
P407
P577
2016-02-06T00:00:00Z